We are live on ! Find out more
IMA

ImageneBio Inc

58 hedge funds and large institutions have $142M invested in ImageneBio Inc in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 3

178% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 9

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

12% more funds holding

Funds holding: 5258 (+6)

0.08% more ownership

Funds ownership: 6.13%6.22% (+0.08%)

31% less capital invested

Capital invested by funds: $205M → $142M (-$63.1M)

Holders
58
Holders Change
+6
Holders Change %
+11.54%
% of All Funds
0.92%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.06%
New
9
Increased
25
Reduced
9
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$302K +$45.5K +756 +15%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$300K +$34.6K +575 +11%
Jacobs Levy Equity Management
28
Jacobs Levy Equity Management
New Jersey
$248K +$148K +2,453 +106%
FAM
29
Fred Alger Management
New York
$186K +$8.31K +138 +4%
CIC
30
Cornercap Investment Counsel
Georgia
$161K -$5.54K -92 -3%
N
31
Nuveen
North Carolina
$143K
Bank of America
32
Bank of America
North Carolina
$129K +$71K +1,179 +91%
OMC
33
OUP Management Company
Pennsylvania
$116K +$135K +2,236 New
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$110K +$19.8K +329 +18%
Two Sigma Investments
35
Two Sigma Investments
New York
$94.1K +$109K +1,811 New
Goldman Sachs
36
Goldman Sachs
New York
$92.6K +$18.2K +303 +20%
JP Morgan Chase
37
JP Morgan Chase
New York
$71.3K -$6.74K -112 -8%
Morgan Stanley
38
Morgan Stanley
New York
$68K +$3.67K +61 +5%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$65.2K +$1.32K +22 +2%
UBS Group
40
UBS Group
Switzerland
$59.1K +$6.56K +109 +11%
Renaissance Technologies
41
Renaissance Technologies
New York
$57K -$5.06K -84 -7%
Mirae Asset Global Investments
42
Mirae Asset Global Investments
South Korea
$54.9K
AIG
43
American International Group
New York
$53.7K +$10.8K +180 +21%
VF
44
Virtu Financial
New York
$51K +$58.6K +973 New
VOYA Investment Management
45
VOYA Investment Management
Georgia
$48.4K +$56.1K +931 New
SG Americas Securities
46
SG Americas Securities
New York
$46K +$53.8K +894 New
Acadian Asset Management
47
Acadian Asset Management
Massachusetts
$44K -$5.96K -99 -10%
Wells Fargo
48
Wells Fargo
California
$26.5K -$10.5K -175 -26%
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$23.7K -$7.95K -132 -22%
Royal Bank of Canada
50
Royal Bank of Canada
Ontario, Canada
$18K +$8.25K +137 +62%

IMA Hedge Fund Activity: Q3 2023 in Review

58 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in ImageneBio Inc (IMA) for Q3 2023, worth a combined $142M — down 31% from $205M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IMA positions and 3 closed out — a net gain of 6 holders — while 25 added to existing stakes and 9 trimmed.

The largest buyer was Verition Fund Management, adding an estimated $3.31M. The largest seller was Fidelity Investments, cutting an estimated $3.07M.

  • 58 institutional investors held ImageneBio Inc (IMA) as of Q3 2023, up from 52 in Q2 2023.
  • Funds reported $142M of ImageneBio Inc stock for Q3 2023, down 31% quarter-over-quarter.
  • 9 funds opened new ImageneBio Inc positions in Q3 2023 and 3 closed out, a net change of +6 holders.
  • The largest ImageneBio Inc buyer in Q3 2023 was Verition Fund Management, an estimated $3.31M added.
  • The largest ImageneBio Inc seller in Q3 2023 was Fidelity Investments, an estimated $3.07M sold.

Based on aggregated 13F filings for Q3 2023.